LNC Therapeutics' Series A Round

LNC Therapeutics raised a round of funding on January 01, 2010. Investors include EPI.

LNC Therapeutics, fka Nutrition Laboratories & Cardio, develops gut microbiota directed drugs to tackle obesity and its associated cardiometabolic diseases.…

Articles about LNC Therapeutics' Series A Round: